Research
-
October 28, 2021
Pancreatic beta-cell booster
Blocking inflammatory signaling improves beta-cell characteristics in a mouse model of type 2 diabetes and may provide added benefits to GLP-1R diabetes medications. -
October 28, 2021
The challenge of rejection
Minimizing variation in how rejection is diagnosed and creating standardized surveillance protocols may help inform best practices in pediatric heart transplants. -
October 28, 2021
VUMC researchers a step closer to broad ebolavirus protection
-
October 28, 2021
Zost honored for research on COVID-19, other life-threatening viral diseases
Vanderbilt's Seth Zost, PhD, has been awarded a major international prize for his research on COVID-19 and other life-threatening viral diseases. -
October 21, 2021
Study links genetic variants, protein expression and human diseases
An international research team has developed a new resource that connects genetic variants and protein expression, which is expected to speed the identification of genes that cause disease — and point to novel treatment strategies. -
October 19, 2021
Combo therapy slows prostate cancer
A new combination treatment showed promise in slowing the growth of castration-resistant prostate cancer in animal models, Vanderbilt researchers discovered. -
October 18, 2021
Berlin Institute of Health’s Eils set for next Discovery Lecture
Roland Eils, PhD, will discuss efforts to translate the deluge of genomics data generated by international initiatives into understanding disease mechanisms during the next web-based Discovery Lecture.